Cellular Biomedicine Group, Inc. CBMG is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, i haMPC human adipose derived mesenchymal progenitor cells for treatment of joint disease, ii huMPC human umbilical cord derived mesenchymal progenitor cells , iii TC DC tumor cell specific dendritic cells for treatment of a broad range of cancers and iv MNP human embryo derived motor neuron precursor cells and NP human embryo derived neuronal precursor cells for treatment of central nervous system diseases.
Quote | Cellular Biomedicine Group Inc. (NASDAQ:CBMG)
|Last Trade Date Time:||02/19/2021 04:55:35 pm|
News | Cellular Biomedicine Group Inc. (NASDAQ:CBMG)
2023-07-02 04:45:00 ET Summary Cellular Biomedicine Group has out-licensed global rights to its two lead CAR-T candidates to Janssen Biotech for $245 million upfront. We have more on latest deals and financings from Sichuan Kelun-Biotech, Sichuan Kelun-Biotech, Lion TCR, Beijing B...
Merger activity decreased last week with four new deals announced. The acquisition of Enable Midstream Partners by Energy Transfer. The acquisition of Tribune Publishing Company by Alden Golden Capital. For further details see: Merger Arbitrage Mondays - Consolidati...
Message Board Posts | Cellular Biomedicine Group Inc. (NASDAQ:CBMG)
|Not sure why they bothered, with this telephone||richrichrich||investorshub||01/30/2021 11:48:35 PM|
|Was hoping for more fan fair after the||Djk0689||investorshub||01/08/2021 7:46:21 PM|
|whytestocks: $CBMG News Article - Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Cont||whytestocks||investorshangout||12/29/2020 9:20:48 PM|
|$CBMG. Theres a big poker game going on||Aitkenresearch||investorshub||08/12/2020 8:38:03 PM|
|Guess it's time to say bye-bye, to Tony||richrichrich||investorshub||08/12/2020 8:33:26 PM|
Cellular Biomedicine Group Inc. Company Name:
CBMG Stock Symbol:
Cellular Biomedicine Group, Inc. Announces Completion of Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Feb. 19, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the completion of the merger (th...
Cellular Biomedicine Group, Inc. Stockholders Approve Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Feb. 8, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting...
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company,...